FDA Finalizes ODT Guidance, Sticks To More Restrictive Recommendations

FDA drew a line in the sand in finalizing a guidance limiting orally disintegrating tablets to a 30-second dissolution time and 500 mg weight, despite industry arguments that such restrictions would discourage development of ODTs